Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 13:07:41 UTC
Update Date2022-09-22 17:44:24 UTC
HMDB IDHMDB0254039
Secondary Accession NumbersNone
Metabolite Identification
Common NameLeucyl-leucine
DescriptionLeucyl-Leucine, also known as L-L dipeptide or leu-leu, belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. Leucyl-Leucine is a very strong basic compound (based on its pKa). Leucyl-Leucine is a dipeptied compoosed of two leucine residues. It is an incomplete breakdown product of protein digestion or protein catabolism. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an 'Expected' metabolite. This compound has been identified in human blood as reported by (PMID: 31557052 ). Leucyl-leucine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Leucyl-leucine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
L-L DipeptideHMDB
L-Leucyl-L-leucineHMDB
Leu-leuHMDB
Leucine leucine dipeptideHMDB
Leucine-leucine dipeptideHMDB
LeucylleucineHMDB
LL DipeptideHMDB
Leucylleucine monohydrochloride, (L-leu-L-leu)-isomerHMDB
Leucylleucine, (L-leu-D-leu)-isomerHMDB
Leucylleucine, (D-leu-D-leu)-isomerHMDB
Leucylleucine, (L-leu-L-leu)-isomerHMDB
Chemical FormulaC12H24N2O3
Average Molecular Weight244.3306
Monoisotopic Molecular Weight244.178692644
IUPAC Name2-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-4-methylpentanoic acid
Traditional Nameleucyl-leucine
CAS Registry NumberNot Available
SMILES
CC(C)CC(N)C(O)=NC(CC(C)C)C(O)=O
InChI Identifier
InChI=1S/C12H24N2O3/c1-7(2)5-9(13)11(15)14-10(12(16)17)6-8(3)4/h7-10H,5-6,13H2,1-4H3,(H,14,15)(H,16,17)
InChI KeyLCPYQJIKPJDLLB-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentPeptides
Alternative Parents
Substituents
  • Alpha peptide
  • Leucine or derivatives
  • N-acyl-alpha-amino acid
  • N-acyl-alpha amino acid or derivatives
  • Alpha-amino acid or derivatives
  • Branched fatty acid
  • Methyl-branched fatty acid
  • Fatty acyl
  • Fatty acid
  • Amino acid or derivatives
  • Amino acid
  • Carboximidic acid
  • Carboximidic acid derivative
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Organic oxide
  • Organic oxygen compound
  • Primary aliphatic amine
  • Amine
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Organonitrogen compound
  • Organooxygen compound
  • Organopnictogen compound
  • Primary amine
  • Carbonyl group
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP-1.4ALOGPS
logP-0.26ChemAxon
logS-2.2ALOGPS
pKa (Strongest Acidic)3.76ChemAxon
pKa (Strongest Basic)9.61ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area95.91 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity65.66 m³·mol⁻¹ChemAxon
Polarizability27.69 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+162.73230932474
DeepCCS[M-H]-159.91330932474
DeepCCS[M-2H]-195.24230932474
DeepCCS[M+Na]+171.38930932474
AllCCS[M+H]+159.932859911
AllCCS[M+H-H2O]+156.832859911
AllCCS[M+NH4]+162.732859911
AllCCS[M+Na]+163.632859911
AllCCS[M-H]-159.632859911
AllCCS[M+Na-2H]-160.732859911
AllCCS[M+HCOO]-162.132859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Predicted by Siyang on May 30, 202211.207 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20225.26 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid1227.3 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid217.7 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid114.5 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid155.3 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid79.1 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid388.9 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid352.6 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)111.8 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid740.2 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid367.1 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1107.6 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid203.4 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid276.5 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate283.1 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA295.0 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water56.1 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Leucyl-leucineCC(C)CC(N)C(O)=NC(CC(C)C)C(O)=O2502.0Standard polar33892256
Leucyl-leucineCC(C)CC(N)C(O)=NC(CC(C)C)C(O)=O1764.3Standard non polar33892256
Leucyl-leucineCC(C)CC(N)C(O)=NC(CC(C)C)C(O)=O1864.8Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Leucyl-leucine,3TMS,isomer #1CC(C)CC(N=C(O[Si](C)(C)C)C(CC(C)C)N[Si](C)(C)C)C(=O)O[Si](C)(C)C1869.6Semi standard non polar33892256
Leucyl-leucine,3TMS,isomer #1CC(C)CC(N=C(O[Si](C)(C)C)C(CC(C)C)N[Si](C)(C)C)C(=O)O[Si](C)(C)C1957.2Standard non polar33892256
Leucyl-leucine,3TMS,isomer #1CC(C)CC(N=C(O[Si](C)(C)C)C(CC(C)C)N[Si](C)(C)C)C(=O)O[Si](C)(C)C2165.3Standard polar33892256
Leucyl-leucine,3TMS,isomer #2CC(C)CC(N=C(O[Si](C)(C)C)C(CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O2091.4Semi standard non polar33892256
Leucyl-leucine,3TMS,isomer #2CC(C)CC(N=C(O[Si](C)(C)C)C(CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O2034.6Standard non polar33892256
Leucyl-leucine,3TMS,isomer #2CC(C)CC(N=C(O[Si](C)(C)C)C(CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O2417.9Standard polar33892256
Leucyl-leucine,3TMS,isomer #3CC(C)CC(N=C(O)C(CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C2083.8Semi standard non polar33892256
Leucyl-leucine,3TMS,isomer #3CC(C)CC(N=C(O)C(CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C2062.5Standard non polar33892256
Leucyl-leucine,3TMS,isomer #3CC(C)CC(N=C(O)C(CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C2395.1Standard polar33892256
Leucyl-leucine,4TMS,isomer #1CC(C)CC(N=C(O[Si](C)(C)C)C(CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C2063.8Semi standard non polar33892256
Leucyl-leucine,4TMS,isomer #1CC(C)CC(N=C(O[Si](C)(C)C)C(CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C2121.1Standard non polar33892256
Leucyl-leucine,4TMS,isomer #1CC(C)CC(N=C(O[Si](C)(C)C)C(CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C2094.5Standard polar33892256
Leucyl-leucine,3TBDMS,isomer #1CC(C)CC(N=C(O[Si](C)(C)C(C)(C)C)C(CC(C)C)N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2482.9Semi standard non polar33892256
Leucyl-leucine,3TBDMS,isomer #1CC(C)CC(N=C(O[Si](C)(C)C(C)(C)C)C(CC(C)C)N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2486.4Standard non polar33892256
Leucyl-leucine,3TBDMS,isomer #1CC(C)CC(N=C(O[Si](C)(C)C(C)(C)C)C(CC(C)C)N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2520.3Standard polar33892256
Leucyl-leucine,3TBDMS,isomer #2CC(C)CC(N=C(O[Si](C)(C)C(C)(C)C)C(CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O2713.4Semi standard non polar33892256
Leucyl-leucine,3TBDMS,isomer #2CC(C)CC(N=C(O[Si](C)(C)C(C)(C)C)C(CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O2535.9Standard non polar33892256
Leucyl-leucine,3TBDMS,isomer #2CC(C)CC(N=C(O[Si](C)(C)C(C)(C)C)C(CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O2669.8Standard polar33892256
Leucyl-leucine,3TBDMS,isomer #3CC(C)CC(N=C(O)C(CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2694.1Semi standard non polar33892256
Leucyl-leucine,3TBDMS,isomer #3CC(C)CC(N=C(O)C(CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2612.3Standard non polar33892256
Leucyl-leucine,3TBDMS,isomer #3CC(C)CC(N=C(O)C(CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2681.5Standard polar33892256
Leucyl-leucine,4TBDMS,isomer #1CC(C)CC(N=C(O[Si](C)(C)C(C)(C)C)C(CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2952.5Semi standard non polar33892256
Leucyl-leucine,4TBDMS,isomer #1CC(C)CC(N=C(O[Si](C)(C)C(C)(C)C)C(CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2808.3Standard non polar33892256
Leucyl-leucine,4TBDMS,isomer #1CC(C)CC(N=C(O[Si](C)(C)C(C)(C)C)C(CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2525.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental GC-MSGC-MS Spectrum - Leucyl-leucine EI-B (Non-derivatized)splash10-000b-7090000000-09a4ae51d224ef58134e2017-09-12HMDB team, MONA, MassBankView Spectrum
Experimental GC-MSGC-MS Spectrum - Leucyl-leucine EI-B (Non-derivatized)splash10-000b-7090000000-09a4ae51d224ef58134e2018-05-18HMDB team, MONA, MassBankView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a4u-9620000000-ad224f4141e887a4a79a2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (1 TMS) - 70eV, Positivesplash10-0079-9410000000-6648432f51d2bdf426e62017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TMS_1_3) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TMS_2_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TMS_2_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TMS_2_3) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TMS_2_4) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TBDMS_1_3) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TBDMS_2_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TBDMS_2_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TBDMS_2_3) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucyl-leucine GC-MS (TBDMS_2_4) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Leucyl-leucine 6V, Positive-QTOFsplash10-000j-9040000000-bd90a66ec34d603f8a572021-09-20HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucyl-leucine 10V, Positive-QTOFsplash10-002b-4590000000-c2a4b3993563cbff43da2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucyl-leucine 20V, Positive-QTOFsplash10-00ks-9300000000-43470fc9b834d53251aa2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucyl-leucine 40V, Positive-QTOFsplash10-0aor-9000000000-6c693ee003b534152bc72017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucyl-leucine 10V, Negative-QTOFsplash10-0006-0390000000-35205291ccaa4dfba9812017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucyl-leucine 20V, Negative-QTOFsplash10-01u4-1930000000-d6e30b556f67e6cada2d2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucyl-leucine 40V, Negative-QTOFsplash10-01q9-9700000000-77c11c820cc945624b8f2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucyl-leucine 10V, Positive-QTOFsplash10-0002-3390000000-91c44390718e7e265c472021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucyl-leucine 20V, Positive-QTOFsplash10-001r-9200000000-a1e7ac1bab71fda5594c2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucyl-leucine 40V, Positive-QTOFsplash10-00ko-9000000000-410f045eb81407bdc5072021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucyl-leucine 10V, Negative-QTOFsplash10-0036-0980000000-4bad646436acf8175e892021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucyl-leucine 20V, Negative-QTOFsplash10-004i-1900000000-bf93797bfac58b2c9a342021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucyl-leucine 40V, Negative-QTOFsplash10-001l-9200000000-7d6fe3eb82ae6d88a12a2021-10-12Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
UrineDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedCancer patients undergoing total body irradiation details
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDC11332
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound94244
PDB IDNot Available
ChEBI ID6418
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]